Peripheral and Central Levels of Kynurenic Acid in Bipolar Disorder Subjects and Healthy Controls

Translational Psychiatry - United Kingdom
doi 10.1038/s41398-019-0378-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Serum Ischemia Modified Albumin (IMA) Levels of Patients With Bipolar Disorder in Remission and Healthy Controls

Biomedical Research
2018English

Vitamin D, Folate and the Intracranial Volume in Schizophrenia and Bipolar Disorder and Healthy Controls

Scientific Reports
Multidisciplinary
2018English

Working Memory Networks and Activation Patterns in Schizophrenia and Bipolar Disorder: Comparison With Healthy Controls

British Journal of Psychiatry
MedicinePsychiatryMental Health
2014English

Bifidobacterium and Lactobacillus Counts in the Gut Microbiota of Patients With Bipolar Disorder and Healthy Controls

Frontiers in Psychiatry
PsychiatryMental Health
2019English

Evaluation of Reproductive Function in Women Treated for Bipolar Disorder Compared to Healthy Controls

Bipolar Disorders
PsychiatryBiological PsychiatryMental Health
2013English

Tryptophan and Kynurenic Acid May Produce an Amplified Effect in Central Fatigue Induced by Chronic Sleep Disorder

International Journal of Tryptophan Research
BiochemistryMolecular Biology
2014English

Perisylvian GABA Levels in Schizophrenia and Bipolar Disorder

Neuroscience Letters
Neuroscience
2017English

Cognitive Performance and Cerebrospinal Fluid Biomarkers of Neurodegeneration: A Study of Patients With Bipolar Disorder and Healthy Controls

PLoS ONE
Multidisciplinary
2015English

Figure 2: Histogram of Levels of Peripheral vWF-Ag and sCD16 in Patients and Healthy Control Subjects.

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy